Lack of efficacy of resveratrol on C-reactive protein and selected cardiovascular risk factors — Results from a systematic review and meta-analysis of randomized controlled trials
Amirhossein Sahebkar(Mashhad University of Medical Sciences), Maciej Banach(Medical University of Lodz), Gregory Y.H. Lip(University of Liverpool), Manfredi Rizzo(Department of Health), Ian Graham, Jacek Rysz(Medical University of Lodz), Paul Muntner(Columbia University), Nathan D. Wong(University of Washington), Laurence Sperling(Emory University), Dimitri P. Mikhailidis(UCL Australia), Sorin Ursoniu(Victor Babeș University of Medicine and Pharmacy Timișoara)
Cited by 175
Related Papers
Global Burden of Cardiovascular Diseases and Risk Factors, 1990–2019
|Journal of the American College of Cardiology|2020|11k
Heart Disease and Stroke Statistics—2019 Update: A Report From the American Heart Association
|Circulation|2019|9.1k
2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults
|Journal of the American College of Cardiology|2017|6.5k